An interim analysis of the Turkish myeloma registry among the patients who have received up to two lines of therapy
| dc.authorid | 0000-0001-9636-4113 | |
| dc.contributor.author | Sevindik, Ömür Gökmen | |
| dc.contributor.author | Özkurt, Zübeyde Nur | |
| dc.contributor.author | Boğa, Can | |
| dc.contributor.author | Kalayoğlu Beşışık, Sevgi | |
| dc.contributor.author | Yıldız, İpek | |
| dc.contributor.author | Gedük, Ayfer | |
| dc.contributor.author | Harmandali, Aybüke | |
| dc.contributor.author | Salihoğlu, Ayşe | |
| dc.contributor.author | Haydaroğlu Şahin, Handan | |
| dc.contributor.author | Sönmez, Mehmet | |
| dc.contributor.author | Vural, Filiz | |
| dc.contributor.author | Akay, Olga Meltem | |
| dc.contributor.author | Kurt Yüksel, Meltem | |
| dc.contributor.author | Maral, Senem | |
| dc.contributor.author | Ekinci, Ömer | |
| dc.contributor.author | Kırkızlar, Hakkı Onur | |
| dc.contributor.author | Tekinalp, Atakan | |
| dc.contributor.author | Demir, Nazlı | |
| dc.contributor.author | Merter, Mustafa | |
| dc.contributor.author | Saydam, Güray | |
| dc.contributor.author | Alacacıoğlu, İnci | |
| dc.contributor.author | Yeğin, Zeynep Arzu | |
| dc.contributor.author | Kaşar, Mutlu | |
| dc.contributor.author | Mastanzade, Metban | |
| dc.contributor.author | Özsan, Güner Hayri | |
| dc.date.accessioned | 2022-09-19T07:23:37Z | |
| dc.date.available | 2022-09-19T07:23:37Z | |
| dc.date.issued | 2021 | |
| dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı | |
| dc.description.abstract | [Abstract Not Available] | |
| dc.identifier.citation | Sevindik, Ö. G., Özkurt, Z. N., Boğa, C., Kalayoğlu Beşışık, S., Yıldız, İ., Gedük, A. ... Özsan, G. H. (2021). An interim analysis of the Turkish myeloma registry among the patients who have received up to two lines of therapy. Blood. https://dx.doi.org/10.1182/blood-2021-150175 | |
| dc.identifier.doi | 10.1182/blood-2021-150175 | |
| dc.identifier.issn | 0006-4971 | |
| dc.identifier.issn | 1528-0020 | |
| dc.identifier.issue | Supplement: 1 | |
| dc.identifier.uri | https://dx.doi.org/10.1182/blood-2021-150175 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12511/9729 | |
| dc.identifier.volume | 138 | |
| dc.identifier.wos | 000835740102199 | en_US |
| dc.identifier.wosquality | Q1 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.institutionauthor | Sevindik, Ömür Gökmen | |
| dc.language.iso | en | |
| dc.publisher | American Society of Hematology | |
| dc.relation.ispartof | Blood | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Analysis | |
| dc.subject | Myeloma | |
| dc.subject | An Interim Analysis | |
| dc.title | An interim analysis of the Turkish myeloma registry among the patients who have received up to two lines of therapy | |
| dc.type | Conference Object |
Dosyalar
Lisans paketi
1 - 1 / 1
Küçük Resim Yok
- İsim:
- license.txt
- Boyut:
- 1.44 KB
- Biçim:
- Item-specific license agreed upon to submission
- Açıklama:











